lobbying_filings_raw: 030a4f97-e7a9-4db6-9177-e55b11420a48
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 030a4f97-e7a9-4db6-9177-e55b11420a48 | 2A | 401104190 | TRAVERE THERAPEUTICS | 200929 | TRAVERE THERAPEUTICS | 2017 | second_quarter | 2017-07-19T10:19:20.580000-04:00 | 170000.0 | 1 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/030a4f97-e7a9-4db6-9177-e55b11420a48/", "filing_uuid": "030a4f97-e7a9-4db6-9177-e55b11420a48", "filing_type": "2A", "filing_type_display": "2nd Quarter - Amendment", "filing_year": 2017, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/030a4f97-e7a9-4db6-9177-e55b11420a48/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "170000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Christopher Porter", "dt_posted": "2017-07-19T10:19:20.580000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "3721 Valley Centre Drive", "registrant_address_2": "Suite 200", "registrant_different_address": false, "registrant_city": "San Diego", "registrant_state": "CA", "registrant_zip": "92130", "registrant": {"id": 401104190, "url": "https://lda.senate.gov/api/v1/registrants/401104190/", "house_registrant_id": null, "name": "TRAVERE THERAPEUTICS", "description": "Pharmaceuticals", "address_1": "3611 Valley Centre Drive", "address_2": "Suite 300", "address_3": null, "address_4": null, "city": "San Diego", "state": "CA", "state_display": "California", "zip": "92130", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "CHRISTOPHER PORTER", "contact_telephone": "+1 877-969-7879", "dt_updated": "2026-01-23T12:45:17.477142-05:00"}, "client": {"id": 200929, "url": "https://lda.senate.gov/api/v1/clients/200929/", "client_id": 12, "name": "TRAVERE THERAPEUTICS", "general_description": "Biopharmaceuticals", "client_government_entity": false, "client_self_select": true, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2016-08-15"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Orphan Drug Act, Drug Quality and Security Act drug safety issues, drug pricing, Prescription Drug User Fee Act reauthorization, FAST Generics and CREATES Acts, FDA issues", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 64866, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PORTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Rare disease patient care, screening, and coverage issues in American Health Care Act and Better Care Reconciliation Act", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 64866, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PORTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "American Health Care Act Medicaid provisions.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 64866, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PORTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Medical research, NIH funding, FDA personnel issues", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 64866, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PORTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "Intellectual property issues and commercial litigation", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 64866, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PORTER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |